Company Spotlight

Top 7 Companies in the Global Autoinjector Market in 2025

Top Companies in the Global Autoinjector Market

Insights

Amgen Inc., Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd, Eli Lilly and Company, Ypsomed AG, Mylan N.V., and GlaxoSmithKline Plc. are some of the leading players in the autoinjector market.

The global autoinjector market was valued at USD 71.58 billion in 2024. The market is expected to grow at a CAGR of 19.1% during the forecast period 2025-2034, with the values likely to reach USD 345.14 billion by 2034. The market is driven by the rising prevalence of chronic diseases and technological advancements globally.

An autoinjector is a medical device designed to facilitate the self-administration of injections, commonly used for treatments related to biologic therapies, allergies, and chronic conditions. It allows patients to deliver medication accurately and safely without the need for a healthcare professional. They are engineered for ease of use, ensuring proper dosage, and minimizing the risk of needle-related injuries. Their compact, user-friendly design offers convenience, making them a popular choice for patients requiring ongoing treatments. They also improve medication adherence and provide an alternative to traditional injections, enhancing the overall healthcare experience.

The global autoinjector market is experiencing significant growth driven by various factors, including the increasing prevalence of chronic diseases such as diabetes, arthritis, and autoimmune disorders, which require regular medication administration. Technological advancements have led to the development of more efficient, compact, and safer autoinjectors, making them increasingly popular among patients. Additionally, the rising demand for self-administration of treatments, particularly in the homecare setting, is boosting the market. Innovations in design and user-centric features further contribute to the market's growth, ensuring a strong trajectory for the future.

In June 2024, the FDA approved the Adbry autoinjector for moderate to severe atopic dermatitis, providing patients with a more convenient self-administration option. This approval highlights the growing trend of advancing patient care through innovative devices. Such developments are anticipated to contribute to the continuous growth of the global autoinjector market.

Let’s explore the profile of top companies leading the global autoinjector market in 2025.

1.    Amgen Inc.

Headquarters California, United States
Establishment 1980
Website https://www.amgen.com/

Amgen, a global biopharmaceutical leader, is at the forefront of the autoinjector market with its Aranesp® (darbepoetin alfa) prefilled SureClick autoinjector. This device simplifies the administration of anemia treatments for patients with chemotherapy-induced anemia and chronic kidney disease. This autoinjector is designed for safety, minimizing needlestick injuries, and ensuring a complete subcutaneous injection with audible indicators. Their commitment to innovation is evident in the widespread availability of this user-friendly autoinjector across clinics, hospitals, and pharmacies.

2.    Becton Dickinson and Company

Headquarters New Jersey, United States
Establishment 1897
Website https://www.bd.com/en-in

Becton, Dickinson and Company (BD) has established itself as a prominent force in the global autoinjector market with its BD Physioject disposable autoinjector 1mL. This innovative, button-activated device provides a user-friendly solution for chronic disease treatments, ensuring accurate dosing and enhanced injection safety. BD’s expertise in medical technology supports the market’s growth by prioritizing patient comfort, improving adherence to therapy, and contributing to the widespread adoption of self-injection systems.

3.    Teva Pharmaceutical Industries Ltd

Headquarters Tel Aviv, Israel
Establishment 1944
Website https://www.tevapharm.com/

Teva Pharmaceutical Industries Ltd. is a global leader in the generic and specialty medicines sector, committed to improving patients' lives worldwide. The company has advanced its position in the autoinjector market by introducing the Ajovy autoinjector for migraine prevention. Ajovy offers flexibility with its quarterly and monthly dosing options, making it a key player in the growing demand for self-administered treatments. Their continued innovation and focus on accessible solutions play a significant role in driving the expansion of the global autoinjector market.

4.    Eli Lilly and Company

Headquarters Indiana, United States
Establishment 1876
Website https://www.lilly.com/in/

Eli Lilly and Company is a global leader in healthcare, with a strong focus on innovative solutions for chronic disease management. By partnering to advance automated insulin delivery systems, the company enhances its presence in the autoinjector market. Their commitment to improving patient outcomes through advanced self-injection technologies supports the increasing demand for user-friendly and efficient drug delivery systems in the healthcare industry.

5.    Ypsomed AG

Headquarters Burgdorf, Switzerland
Establishment 2003
Website https://www.ypsomed.com/en/

Ypsomed is a prominent company in the market, specializing in the design and development of advanced self-injection systems. Their YpsoMate series, including the YpsoMate 2.25 and YpsoMate 5.5, offers convenient, user-friendly solutions for biologic treatments. The company’s innovations, such as the SmartPilot and YpsoMate On, bring digital health integration, enhancing precision and patient compliance. Their products are likely to support the market’s expansion, addressing the rising demand for self-administration devices.

6.    Mylan N.V.

Headquarters Pennsylvania, United States
Establishment 1961
Website https://www.viatris.com/en

Mylan is a global pharmaceutical company that has significantly contributed to the autoinjector market, particularly with the EpiPen autoinjector. The company launched the first authorized generic for the EpiPen, offering patients a more affordable option for emergency allergic reaction treatments. Their commitment to patient access, along with its strong presence in the generic market, supports the growing demand for autoinjector solutions in allergy and anaphylaxis care.

7.    GlaxoSmithKline Plc

Headquarters London. United Kingdom
Establishment 2000
Website https://www.gsk.com/en-gb/

GSK plc, a prominent global biopharma company, has made strides in the autoinjector market with the approval of the Benlysta (belimumab) autoinjector in May 2024. This approval marks the first-ever at-home treatment for pediatric patients aged five and older with systemic lupus erythematosus (SLE), providing a 200 mg subcutaneous option. The innovation addresses the rising demand for self-administered therapies, supporting GSK’s position in the growing global autoinjector market and enhancing treatment flexibility for patients and caregivers.

How to Purchase a Report

Website

To place an order through our website, select the license type mentioned on the report details page. Click on the ‘Buy Now’ button and fill in your details. Select your preferred mode of payment after which you will be redirected to the selected payment gateway. Follow the steps and proceed to checkout.

www.expertmarketresearch.com

Email

Enlisting all your requirements and queries along with details that include billing and delivery address and the preferred payment mode. Our customer service representative will revert to you within 24 hours.

[email protected]

Telephone

To place an order through telephone, call our sales team on the following numbers and our customer service representative will help you regarding the same.

+61 291 889 415

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124